LexDanaLexDanabeta
Inventor

Charles Uzarama

Inventor
Laval, CA

Overview

3→
Patents
2017–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07CAcyclic or carbocyclic compounds25%
PatentTitleYear
10,813,898Solid dosage forms of vigabatrin202010,059,660Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto20189,546,135'Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto'2017

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2017–2018Patents assigned to MILLENDO THERAPEUTICS INC (2)· patent assignee history
2017Patents assigned to ATTEROCOR INC (1)· patent assignee history
2017–2020Based in Laval, CA· patent location history
2020Patents assigned to ORPHELIA PHARMA (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MILLENDO THERAPEUTICS INC22017–2018
ATTEROCOR INC12017
ORPHELIA PHARMA12020
Locations
LocationPatentsSpan
Laval, CA32017–2020